BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jie X, Chen Y, Zhao Y, Yang X, Xu Y, Wang J, Meng R, Zhang S, Dong X, Zhang T, Yang K, Xu S, Wu G. Targeting KDM4C enhances CD8+ T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer. J Immunother Cancer 2022;10:e003716. [PMID: 35121645 DOI: 10.1136/jitc-2021-003716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Han D, Zhang J, Bao Y, Liu L, Wang P, Qian D. Anlotinib enhances the antitumor immunity of radiotherapy by activating cGAS/STING in non-small cell lung cancer. Cell Death Discov 2022;8:468. [DOI: 10.1038/s41420-022-01256-2] [Reference Citation Analysis]
2 Dai X, Zeng M, Huang Z, Zhang J, Wei Z, Wang Z. A Novel Prognostic Chemokine-Related lncRNAs Signature Associated with Immune Landscape in Colon Adenocarcinoma. Disease Markers 2022;2022:1-38. [DOI: 10.1155/2022/2823042] [Reference Citation Analysis]
3 Zhang N, Wang D, Hu X, Zhang G, Li Z, Zhao Y, Liu Z, Wang Y. Analysis of immune status in gastric adenocarcinoma with different infiltrating patterns and origin sites. Front Immunol 2022;13:978715. [DOI: 10.3389/fimmu.2022.978715] [Reference Citation Analysis]
4 Zhou X, Zhou R, Rao X, Hong J, Li Q, Jie X, Wang J, Xu Y, Zhu K, Li Z, Wu G. Activated amino acid response pathway generates apatinib resistance by reprograming glutamine metabolism in non-small-cell lung cancer. Cell Death Dis 2022;13:636. [DOI: 10.1038/s41419-022-05079-y] [Reference Citation Analysis]
5 Li H, Wu M, Zhao X. Role of chemokine systems in cancer and inflammatory diseases. MedComm (2020) 2022;3:e147. [PMID: 35702353 DOI: 10.1002/mco2.147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]